What We're Reading: Page 233
Industry reads hand-picked by our editors
Dec 21, 2018
Dec 20, 2018
Dec 19, 2018
-
The Washington Post
Congressional report: Drug companies, DEA failed to stop flow of millions of opioid pills
-
Bloomberg
GE is said to file confidentially for health unit's IPO
-
Healthcare Dive
Federal judge suggests CVS-Aetna be monitored by outside appointee
-
The New York Times
A doctor's guide to what to read on the opioid crisis
Dec 18, 2018
-
Journal of the National Cancer Institute
Cost-Effective But Unaffordable: The CAR-T Conundrum
-
Politico
Warren bill would get feds into generic drug manufacturing
-
Boston Business Journal
Boston biotech Entrada launches with $59M to tackle deadly disease
-
Kaiser Health News
Health care is where the jobs are. But what kind of jobs?
Dec 17, 2018
-
Financial Times
Novartis weighs reinsurance tie-up to fund ultra-expensive drugs
-
in-PharmaTechnologist
2018: An inflection point for generics
-
The New York Times
Dr. Google is a liar
-
The Washington Post
On a bat's wing and a prayer
Dec 14, 2018
-
Reuters
J&J knew for decades that asbestos lurked in its Baby Powder
-
The BMJ
Key opinion leaders' guide to spinning a disappointing clinical trial result
-
The New York Times
NIH to scrutinize private donations to scientific research projects
-
STAT
China’s history with AIDS explains a puzzling aspect of the 'CRISPR babies’ story
Previous
